Darcy J. P. Bates

发表

Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo

A. Eastman, D. Bates, A. Danilov, 2013, Leukemia.

Vinblastine Rapidly Induces NOXA and Acutely Sensitizes Primary Chronic Lymphocytic Leukemia Cells to ABT-737

A. Eastman, D. Bates, C. Lowrey, 2013, Molecular Cancer Therapeutics.

Microtubule destabilising agents: far more than just antimitotic anticancer drugs

A. Eastman, D. Bates, Darcy J. P. Bates, 2017, British journal of clinical pharmacology.

Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105

A. Eastman, D. Bates, A. Danilov, 2016, Cancer biology & therapy.

Multiple BH3 Mimetics Antagonize Antiapoptotic MCL1 Protein by Inducing the Endoplasmic Reticulum Stress Response and Up-regulating BH3-only Protein NOXA*

A. Eastman, D. Bates, B. Salerni, 2011, The Journal of Biological Chemistry.

Toward a cure for chronic lymphocytic leukemia: an attack on multiple fronts

A. Eastman, D. Bates, A. Danilov, 2013, Expert review of anticancer therapy.

Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer

A. Eastman, D. Bates, E. Demidenko, 2016, Clinical Cancer Research.

Manipulating the apoptotic pathway: potential therapeutics for cancer patients.

D. Bates, L. Lewis, Darcy J. P. Bates, 2013, British journal of clinical pharmacology.

Vinblastine sensitizes leukemia cells to cyclin-dependent kinase inhibitors, inducing acute cell cycle phase-independent apoptosis

A. Eastman, D. Bates, B. Salerni, 2011, Cancer biology & therapy.

Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer

D. Bates, E. Demidenko, K. Shee, 2017, Oncotarget.